Artiva Biotherapeutics (ARTV) Other Gross PP&E Adjustments (2023 - 2025)
Historic Other Gross PP&E Adjustments for Artiva Biotherapeutics (ARTV) over the last 3 years, with Q3 2025 value amounting to $3.5 million.
- Artiva Biotherapeutics' Other Gross PP&E Adjustments rose 26075.66% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year increase of 26075.66%. This contributed to the annual value of -$1.5 million for FY2024, which is 6948.57% up from last year.
- Per Artiva Biotherapeutics' latest filing, its Other Gross PP&E Adjustments stood at $3.5 million for Q3 2025, which was up 26075.66% from $1.3 million recorded in Q2 2025.
- In the past 5 years, Artiva Biotherapeutics' Other Gross PP&E Adjustments registered a high of $3.5 million during Q3 2025, and its lowest value of -$4.9 million during Q4 2023.
- Moreover, its 3-year median value for Other Gross PP&E Adjustments was -$1.5 million (2024), whereas its average is -$963000.0.
- In the last 5 years, Artiva Biotherapeutics' Other Gross PP&E Adjustments skyrocketed by 6948.57% in 2024 and then soared by 26075.66% in 2025.
- Artiva Biotherapeutics' Other Gross PP&E Adjustments (Quarter) stood at -$4.9 million in 2023, then skyrocketed by 69.49% to -$1.5 million in 2024, then skyrocketed by 334.98% to $3.5 million in 2025.
- Its Other Gross PP&E Adjustments was $3.5 million in Q3 2025, compared to $1.3 million in Q2 2025 and $109000.0 in Q1 2025.